|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Medicine (Drs. Loredo, Ziegler, and Clausen) and the Department of Psychiatry (Drs. Dimsdale and Ancoli-Israel), University of California, San Diego, San Diego, CA.
Correspondence to: José S. Loredo, MD, UCSD Medical Center Department of Medicine, 200 West Arbor Dr, San Diego, CA 92103-8378; e-mail: jloredo{at}ucsd.edu
| Abstract |
|---|
|
|
|---|
Design: We examined the association of 11 variables measuring sympathetic activity, including plasma norepinephrine (NE), urinary NE, and BP measurements, with movement and cortical arousals.
Patients: Sixty-seven subjects with various degrees of hypertension and OSA were evaluated. All patients were free from antihypertensive medications.
Results: The age
(range, 35 to 60 years), weight (range, 100 to 150% of ideal body
weight), and diet of the subjects were similar. The movement arousal
index was correlated with daytime baseline plasma NE (BNE), daytime
urine NE, mean daytime diastolic BP, and systolic BP during rapid eye
movement sleep (r = 0.39 to 0.53; p
0.002). Cortical arousals did
not correlate with any of the variables. A multiple regression
procedure was performed to examine how well movement arousals predicted
those variables with significant correlations. The respiratory
disturbance index (RDI) and nighttime pulse oxyhemoglobin saturation
were included in the regression equation due to their close association
with movement arousals. Movement arousals independently predicted BNE
(t [48] = 2.06; p < 0.05). No other variable independently
predicted any of the measurements of sympathetic activity.
Conclusions: These findings suggest that movement arousals may influence daytime sympathetic tone independently of RDI and nighttime saturation.
Key Words: arousals BP norepinephrine obstructive sleep apnea sympathetic nervous system
| Introduction |
|---|
|
|
|---|
Increases in SNS activity is a frequently invoked hypothesis for the mechanism of the development of hypertension in patients with obstructive sleep apnea (OSA).5 6 7 Hypoxia increases sympathetic nerve firing,8 especially in the presence of upper airway obstruction such as during an apneic event.4 9 Measurement of plasma and urinary catecholamines also support higher sympathetic activity in sleep apnea patients.10 11 12 13 One of the characteristics of sleep apnea patients is their high frequency of arousals from sleep. However, it is not known if arousals contribute to the tonic activation of the SNS described in OSA.
The measurement of arousals is not well standardized. In recent work, we found that two categories of arousals (increases in EEG frequency > 3 s in duration, and arousals associated with muscle activity) were particularly reliable on test-retest and between readers.14 The possible association of arousals from sleep and SNS function in normal subjects or sleep apnea patients has not been fully evaluated. We set out to determine if arousals influenced SNS functioning in a heterogeneous group of patients with and without OSA and with and without hypertension. We hypothesized that arousals significantly influence tonic SNS function.
| Materials and Methods |
|---|
|
|
|---|
20 were considered to have OSA. Subjects were excluded if
they were receiving medications known to affect sleep or if they had
congestive heart failure; symptomatic obstructive pulmonary, coronary,
or cerebral vascular disease; history of life threatening arrhythmias;
cardiomyopathy; history of psychosis; narcolepsy; or current alcohol or
drug abuse.
Experimental Design
Subjects were admitted to the Clinical Research Center at 5:00
PM and were immediately placed on an isocaloric diet
providing 170 mEq Na and 100 mEq K per day. Sleep was recorded on 2
consecutive nights with polysomnography (model 4412P; Nihon Koden;
Irvine, CA) that recorded central and occipital EEG, bilateral
electro-oculography, submental and tibialis anterior electromyography
(EMG), ECG, nasal/oral airflow using a thermistor, and respiratory
effort using chest and abdominal inductance belts. Pulse oxyhemoglobin
saturation (SpO2) was monitored using a pulse
oximeter (Biox 3740; Ohmeda; Louisville, CO) and analyzed using
appropriate software (Profox Version PFD 6/97; Profox
Associates; Escondido, CA).16
Sleep records were scored
according to the criteria of Rechtshaffen and Kales.17
Apneas were defined as decrements in airflow
90% from baseline for
a period
10 s. Hypopneas were defined as a decrement in airflow
50% but < 90% from baseline for a period
10 s. The number
of apneas and hypopneas per hour were calculated to obtain an RDI.
On both nights, BP measurements were taken every hour using a BP monitor (Dinamap 1846 SX-P; Critikon; Tampa Bay, FL). On night 2, venous blood samples were obtained hourly via a heparinized catheter from an adjoining room. Blood samples were immediately placed in crushed ice and were then spun down in a refrigerated centrifuge. Plasma was stored at -80°C until the time of assay. Plasma norepinephrine (NE) was measured using a radioenzymatic assay.18
On the second hospitalization day, two 12-h urine collections (6:00 AM to 6:00 PM, and 6:00 PM to 6:00 AM) for NE were completed. Urine collections were stored appropriately until the time of assay. NE was measured using a radioenzymatic assay,18 and it is expressed in nanograms excreted per 12 h or 24 h as appropriate.
Arousal Definitions
The definition of an arousal from sleep was based on the
criteria published in the 1992 American Sleep Disorders
Association report on EEG arousals.19
However we
stratified arousals by the presence or absence of increased chin EMG
and/or leg movement. Two different definitions of arousal were used:
(A) shifts in EEG frequency to alpha or theta
3 s but < 15 s
duration (cortical arousals); (B) shifts in EEG frequency
3 s but
< 15 s duration, associated with a rise in chin EMG amplitude and/or
a rise in leg EMG activity (movement arousals). Before an arousal could
be scored, the subject had to have been sleeping for a minimum of
10 s in the same or the contiguous sleep epoch. A minimum of
10 s of intervening sleep was necessary to score a second arousal.
Shifts in EEG frequency were scored from either or both of the EEG
derivations (occipital or central). The abrupt appearance of K
complexes was scored as an arousal only if accompanied by an obvious
shift in EEG frequency. Arousal indexes were calculated by dividing the
number of arousals by the total sleep time (TST). Arousals preceded by
a leg movements or occurring within 30 s of a BP measurement or
blood sampling were excluded. Changes in EEG frequency > 15 s
duration were considered awakenings rather than arousals, and they were
not counted.
Statistical Analysis
To eliminate first night effect, all sleep and BP measurements
used in the analyses reflect the values obtained during night 2. Due to
missing values, only variables with > 50 measurements were included.
Differences among the subject groups at baseline were assessed using
two-way analyses of variance. Post hoc analyses were done
using the independent sample t test.
Pearson correlations with Bonferroni corrections were performed using all subjects to examine the association between cortical arousals and movement arousals, and 11 different variables related to the following: (1) urinary NE; (2) plasma NE; and (3) BP. A multiple regression procedure was then performed to examine how well arousals predicted those variables with significant correlations from each of the above three groups. RDI and nighttime SpO2 were included in the regression analysis because of their close association to arousals. Statistical analyses were performed using appropriate statistical software packages (SPSS for Windows 7.0; SPSS; Chicago, IL).
Sample size estimation was done based on several variables measured in
our previous studies using a t test with a pooled estimate
of the variance. Our calculations suggested that a sample size of 15
subjects per group would be adequate to detect differences in plasma NE
of 0.068 ng/ml with 80% power (
= 0.05; two-tailed).
| Results |
|---|
|
|
|---|
|
|
|
| Discussion |
|---|
|
|
|---|
Despite our efforts to control for potentially confounding factors, apneic subjects were slightly older than nonapneic subjects (p < 0.05). However, age was probably not a factor, because it did not correlate with those measurements of SNS activity correlated with MAI.
Both hypertension and OSA were associated with higher MAI. Sleep apnea was the stronger of the two factors. This is probably related to the strong association of MAI to RDI noted in this study. However, it is unclear why hypertension was associated with a higher MAI, since hypertension did not influence RDI in our sample population (Table 1) . CAIs were similar in all groups, suggesting that CAI is not associated with RDI. Both urinary and plasma NE levels were higher in sleep apneic subjects, which supports the reported higher SNS activity in OSA.7
Both TST and sleep efficiency were low for all groups, suggesting significantly disturbed sleep. While these findings are not unusual for sleep apneic patients (50% of our subjects), normal subjects usually have higher values. We are not sure why the sleep duration was limited in our sample population. The question of whether or not sleep quality affects NE levels is controversial. Some have reported that sleep efficiency is associated with urine NE levels25 26 ; however, others have reported that sleep deprivation had no influence in urinary catecholamine levels27 28 nor awakenings that influenced plasma catecholamines.29 We have previously evaluated the relative importance of some of the most common markers of sleep quality in alterations of the SNS. TST, sleep efficiency, slow wave sleep, and wake after sleep onset were unrelated to 24-h urine NE levels.30
Subjects with OSA often suffer from hundreds of brief arousals each night, probably because arousals play an important part in opening the airway at the end of an apnea. However not all arousals are associated with a respiratory event. The literature also suggests that sleep apneic subjects have higher than normal tonic SNS activity even while awake.7 The most logical stimuli to increase SNS activity in OSA include the respiratory disturbances during sleep and oxyhemoglobin desaturation. Therefore, it was interesting to note that movement arousals were correlated with some measurements of daytime SNS activity, namely, BNE, daytime urine NE, and MDBP. Movement arousals were also correlated with REM sleep SBP (Table 2) .
MAI and RDI were highly correlated in this sample. We wondered if the observed correlation between movement arousals and daytime SNS measurements were a function of the respiratory disturbance or nighttime episodic desaturation, rather than the effect of the arousals themselves. MAI, RDI, and SpO2 together accounted for a modest but significant percent of the variances for BNE, daytime urine NE, and REM SBP. However, only MAI independently predicted BNE when all independent variables were entered simultaneously in the multiple regression equation (Table 3) .
It is difficult to determine what component of a movement arousal (EEG or EMG activity) most influences sympathetic functioning. However, our findings suggest that increases in EMG activity during an arousal best correlate with SNS activity during wakefulness.
In conclusion, in a heterogeneous population, arousals that include increases in EMG activity correlate with daytime plasma NE levels. These findings suggest that movement arousals influence daytime sympathetic tone independently of RDI and nighttime saturation.
| Footnotes |
|---|
This work was supported in part by NIH grants HL44915, AG02711, AG08415, and RR00827.
Received for publication July 14, 1998. Accepted for publication March 31, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. Zintzaras and A. G. Kaditis Sleep-Disordered Breathing and Blood Pressure in Children: A Meta-analysis Arch Pediatr Adolesc Med, February 1, 2007; 161(2): 172 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tauman, A. Ivanenko, L. M. O'Brien, and D. Gozal Plasma C-Reactive Protein Levels Among Children With Sleep-Disordered Breathing Pediatrics, June 1, 2004; 113(6): e564 - e569. [Abstract] [Full Text] |
||||
![]() |
P M Turkington, V Allgar, J Bamford, P Wanklyn, and M W Elliott Effect of upper airway obstruction in acute stroke on functional outcome at 6 months Thorax, May 1, 2004; 59(5): 367 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Chasens, T. E. Weaver, and M. G. Umlauf Insulin Resistance and Obstructive Sleep Apnea: Is Increased Sympathetic Stimulation the Link? Biol Res Nurs, October 1, 2003; 5(2): 87 - 96. [Abstract] [PDF] |
||||
![]() |
A. Blasi, J. Jo, E. Valladares, B. J. Morgan, J. B. Skatrud, and M. C. K. Khoo Cardiovascular variability after arousal from sleep: time-varying spectral analysis J Appl Physiol, October 1, 2003; 95(4): 1394 - 1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Solin, D. M. Kaye, P. J. Little, P. Bergin, M. Richardson, and M. T. Naughton Impact of Sleep Apnea on Sympathetic Nervous System Activity in Heart Failure Chest, April 1, 2003; 123(4): 1119 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Dart, J. R. Gregoire, D. D. Gutterman, and S. H. Woolf The Association of Hypertension and Secondary Cardiovascular Disease With Sleep-Disordered Breathing Chest, January 1, 2003; 123(1): 244 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Redwine, J. Dang, M. Hall, and M. Irwin Disordered Sleep, Nocturnal Cytokines, and Immunity in Alcoholics Psychosom Med, January 1, 2003; 65(1): 75 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.M. Turkington, J. Bamford, P. Wanklyn, and M.W. Elliott Prevalence and Predictors of Upper Airway Obstruction in the First 24 Hours After Acute Stroke Stroke, August 1, 2002; 33(8): 2037 - 2042. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Elmasry, E. Lindberg, J. Hedner, C. Janson, and G. Boman Obstructive sleep apnoea and urine catecholamines in hypertensive males: a population-based study Eur. Respir. J., March 1, 2002; 19(3): 511 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Yan, T. D. Bradley, and P. P. Liu The Role of Continuous Positive Airway Pressure in the Treatment of Congestive Heart Failure Chest, November 1, 2001; 120(5): 1675 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kraiczi, K. Caidahl, A. Samuelsson, Y. Peker, and J. Hedner Impairment of Vascular Endothelial Function and Left Ventricular Filling : Association With the Severity of Apnea-Induced Hypoxemia During Sleep Chest, April 1, 2001; 119(4): 1085 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Samet, F. Javier Nieto, and N. M. Punjabi Sleep-disordered Breathing and Hypertension: More Research Is Still Needed Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1409 - 1411. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |